Health News: ALLENDALE, The main intention of the treatment is to ensure quality life for heart patients from the first stage of medication until the final stage of treatment. NeoStem, Inc. (nyse mkt:NBS), a leader in the emerging cellular therapy industry, ...
[Published KeralaNext.com - May 13 2013]